Role of serum nitrogen oxide in treated hypertensive and normotensive subjects

Authors

  • A. Dasgupta Associate Professor, Department of Anatomy, Konaseeema Institute of Medical Sciences and Research Foundation, Andhra Pradesh-533204.
  • Aditi Saha Post-graduate student, Department of Biochemistry, Konaseeema Institute of Medical Sciences and Research Foundation, Andhra Pradesh-533204
  • G. V. Banerjee Professor, Department of Biochemistry, Konaseeema Institute of Medical Sciences and Research Foundation, Andhra Pradesh-533204
  • P. Karak Assistant Professor,Department of Physiology, Bankura Christian College, Bankura-722101, West Bengal.

DOI:

https://doi.org/10.7439/ijbar.v6i5.1990

Abstract

Background: Hypertension is a leading cause of mortality and morbidity worldwide. Essential hypertension is characterized by endothelial dysfunction and increased vascular tone and resistance. The former is the result of imbalance of endothelium derived contracting and relaxing factors. Nitric oxide which is produced locally by endothelium is crucial for maintaining vascular tone. Aims and Objectives: To study the role of nitric oxide in hypertensive cases and also find out the normal level of serum nitric oxide in the specific population of the district East Godavari, Andhra Pradesh. Materials and Methods: A total of 60 hypertensive and non-diabetic patients aged between 30 years to 72 years; (Male: Female =1.3:1) was taken for the study. Serum creatinine was measured and hypertensives having elevated serum creatinine (>0.3 mg/dl) were excluded from the study; this was done to rule out any effect of kidney functional status on level of serum nitric oxide. Serum nitrate was measured using colorimetric Griess assay. The data was analyzed using SAS 9.1 Results: The mean serum nitrate in hypertensive patients (43.77

Downloads

Download data is not yet available.

References

Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens, 1998; 16: 1979-87.

Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med, 1990; 323:22-27.

Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response to essential hypertension. Circulation, 1990; 81:1762-1767.

Treiber FA, Jackson RW, Davis H, Pollock JS, Kapuku G, Mensah GA, et al. Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension, 2000; 35: 722-5.

Nava E, Luscher TF. Endothelium-derived vasoactive factors in hypertension: Nitric oxide and endothelin. J Hypertens, 1995; 13: S39-48.

Schiffrin EL. Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension, 1995; 25: 1135-43.

Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Descamps-Latscha B, Drueke TB, et al. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl, 2001; 78: S243-5.

Nava E, Luscher TF. Endothelium-derived vasoactive factors in hypertension: Nitric oxide and endothelin. J Hypertens, 1995; 13: S39-48.

Schiffrin EL. Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension, 1995; 25: 1135-43.

Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Descamps-Latscha B, Drueke TB, et al. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl, 2001; 78: S243-5.

Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1986; 332: 411-415.

Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation, 1996; 93: 1860-70.

Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, et al. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation, 1998; 97: 752-6.

Falloon BJ, Heagerty AM. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension, 1994; 24:16-23.

Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation, 1993; 87: 1468-1474.

Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980; 288:373-376.

Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet, 1989; 2: 997-1000.

Zhang SH, Ding JS, Jiao Y, Zhang Q, Peng H, Gao X, Xu YY, Zhang YH. Association between serum nitric oxide and hypertension among 1453 women in Suzhou. Zhonghua Liu Xing Bing XueZaZhi, 2011 Aug; 32(8): 760-3.

Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem, 1982; 126:131-138.

Khazaei M, Nematbakhsh M. The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-Salt hypertensive ovariectomized rats. Regul Pept, 2006 Jul 15; 135(1-2): 91-4.

Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. Lack of evidences for linkage of endothelial nitric oxide synthase gene to essential hypertension. Circulation, 1995 Jan 1; 91(1): 96-102.

Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, et al. Nictric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol, 1997; 29: 308-17.

Sarafidis PA, McFarlane SI, Bakris GL. Antihypertensive agents, insulin sensitivity, and new-onset diabetes. Curr Diab Rep, 2007; 7: 191-9.

Jin L, Caldwell RB, Li-Masters T, Caldwell RW. Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol, 2007; 58: 191-206.

Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, et al. Nictric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol, 1997; 29: 308-17.

Goch A, Banach M, Mikhailidis DP, Rysz J, Goch JH. Endothelial dysfunction in patients with noncomplicated and complicated hypertension. Clin Exp Hypertens, 2009 Feb; 31(1): 20-30.

Cotton S, Mule G, Amato F. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure. J Nephrol, 2002 Dec; 15(6): 643-8.

Lim PO, Tzemos N, Farquharson CA, Anderson JE, Deegen P, Mac Walter RS, Struthers AD, Mac Donald TM. Reversible hypertension following celiac disease treatment: the role of moderate hyperhomocysteinemia and vascular endothelial dysfunction. J Hum Hypertens, 2002; 54:204-9.

Biljana Gerasimovska. Decreased Nitric Oxide in woman with essential hypertension in prehypertensive phase. Croat Med J, 2005; 40(6): 889-893.

Afrasyap, L., Ozturk, G. NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochemica Biophisica Sinica, 2004; 36(10): 661

Kumar, C. A., & Das, U. N. Lipid peroxides, antioxidants and nitric oxides in patients with pre-eclampsia and essential hypertension. Medical Science Monitor, 2000; 6: 901

Node, K., Kitakaze, M., Yoshikawa, H., Kosaka, H., & Hori, M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension, 1997; 30: 405-408.

Kurdanova MKH, Beslaneev IA, Batyrbekova LM, Berkhamova ZA, Sarbasheva AKH, Kurdanov KHA. The nitric oxide system in patients with arterial hypertension living in high mountains. Ter Ark, 2007; 79(12): 25-8.

Pathak N, Sawhney H, vasishta K, majumdarS.Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia. Aust n z j obstetgynaecol. 1999 Nov; 39(4): 484-7.

Bartha JL, Comino-Delgado R, Bedoya FJ, Barahona M, Lubian D, Garcia-Benasach F. Maternal serum nitric oxide levels associated with biochemical and clinical parameters in hypertension in pregnancy. Eur J Obstet Gynecol Reprot Biol, 1999 Feb; 82(2): 201-7.

Kumar CA, Das UN. Lipid peroxides, antioxidants and nitric oxide in patients with pre- eclampsia and essential hypertension. Med Sci Monit, 2000 Sep-Oct; 6(5): 901-7.

Khazaei M, Zarei M, Sharifi MR, Pourshanazari AA. Effect of hypertension and its reverse on serum nitric oxide concentration and vascular permeability in two-kidney one-clip hypertensive rats. Gen Physiol Biophys, 2011 Jun; 30(2): 115-20.

Ferlito, S., Gallina, M., Pitari, G. M., & Bianchi, A. Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disorders. Panminervamedica, 1998; 40(1): 51

Klahr, S. The role of nitric oxide in hypertension and renal disease progression. Nephrology, Dialysis, Transplantation, 2001; 1 (16): 60

Kumar, C. A., & Das, U. N. Lipid peroxides, antioxidants and nitric oxides in patients with pre-eclampsia and essential hypertension. Medical Science Monitor, 2000; 6: 901

Jeerooburkhan, N., Jones, L. C.; Bujac, S. Cooper, J. A., Miller, G. J., Vallance, P., Humphries, S. E., &Hingorani, A. D. Genetic and environmental determinants of plasma nitric oxides and risk of ischemic heart disease. Hypertension, 2001; 38: 1054

Ghasemi A, ZahediAsl S, Mehrabi Y, Saadat N, Azizi F. Serum Nitric Oxide Metabolite Levels In A General Healthy Population: Relation To Sex And Age. Life Sci. 2008 Aug 29; 83(9-10): 326-31.

Ghasemi A, Zahediasl S, AziziF.Reference Values for Serum Nitric Oxide Metabolites in an Adult Population. Clin Biochem. 2010 Jan; 43(1-2):89-94.

Enyioma N. Obineche, Abdishakur M. Abdulle, Javid Y Pathan and Nico J.D. Plasma Endothelin-1, Homocysteine, and Nitric Oxide Levels in a Multiethnic Hypertensive Cohort from the United Arab Emirates. Nagelkerke Journal of Medical Sciences (2010); 3(3): 153-159.

Sainani GS, Maru VG. Role of endothelial cell dysfunction in essential hypertension. J. Assoc Physicians India. 2004 Dec; 52: 966-99.

Downloads

Published

2015-05-04

Issue

Section

Original Research Articles

How to Cite

1.
Role of serum nitrogen oxide in treated hypertensive and normotensive subjects. Int J of Biomed & Adv Res [Internet]. 2015 May 4 [cited 2024 Oct. 18];6(5):406-12. Available from: https://ssjournals.co.in/index.php/ijbar/article/view/1990